Annual FCF
-$30.11 M
+$1.78 M+5.58%
31 December 2022
Summary:
Better Therapeutics annual free cash flow is currently -$30.11 million, with the most recent change of +$1.78 million (+5.58%) on 31 December 2022. During the last 3 years, it has fallen by -$22.03 million (-272.69%). BTTX annual FCF is now -272.69% below its all-time high of -$8.08 million, reached on 31 December 2020.BTTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$5.88 M
-$287.00 K-5.13%
30 September 2023
Summary:
Better Therapeutics quarterly free cash flow is currently -$5.88 million, with the most recent change of -$287.00 thousand (-5.13%) on 30 September 2023. BTTX quarterly FCF is now -83.71% below its all-time high of -$3.20 million, reached on 31 March 2021.BTTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$27.40 M
+$1.51 M+5.22%
30 September 2023
Summary:
Better Therapeutics TTM free cash flow is currently -$27.40 million, with the most recent change of +$1.51 million (+5.22%) on 30 September 2023. BTTX TTM FCF is now -756.55% below its all-time high of -$3.20 million, reached on 31 March 2021.BTTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTTX Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | -272.7% | +14.7% | -76.0% |
5 y5 years | - | - | - |
BTTX Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -272.7% | +5.6% | -5.1% | +64.0% | -76.0% | +31.0% |
5 y | 5 years | -272.7% | +5.6% | -83.7% | +64.0% | -756.5% | +31.0% |
alltime | all time | -272.7% | +5.6% | -83.7% | +64.0% | -756.5% | +31.0% |
Better Therapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | -$5.88 M(+5.1%) | -$27.40 M(-5.2%) |
June 2023 | - | -$5.59 M(-39.5%) | -$28.91 M(-5.1%) |
Mar 2023 | - | -$9.24 M(+37.9%) | -$30.45 M(+1.1%) |
Dec 2022 | -$30.11 M | -$6.70 M(-9.3%) | -$30.11 M(-24.2%) |
Sept 2022 | - | -$7.39 M(+3.5%) | -$39.74 M(+1.3%) |
June 2022 | - | -$7.13 M(-19.8%) | -$39.24 M(+4.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$8.89 M(-45.5%) | -$37.58 M(+17.9%) |
Dec 2021 | -$31.89 M(+294.7%) | -$16.32 M(+137.0%) | -$31.89 M(+104.9%) |
Sept 2021 | - | -$6.89 M(+25.6%) | -$15.57 M(+79.3%) |
June 2021 | - | -$5.48 M(+71.3%) | -$8.68 M(+171.3%) |
Mar 2021 | - | -$3.20 M | -$3.20 M |
Dec 2020 | -$8.08 M(-9.8%) | - | - |
Dec 2019 | -$8.95 M | - | - |
FAQ
- What is Better Therapeutics annual free cash flow?
- What is the all time high annual FCF for Better Therapeutics?
- What is Better Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Better Therapeutics?
- What is Better Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Better Therapeutics?
What is Better Therapeutics annual free cash flow?
The current annual FCF of BTTX is -$30.11 M
What is the all time high annual FCF for Better Therapeutics?
Better Therapeutics all-time high annual free cash flow is -$8.08 M
What is Better Therapeutics quarterly free cash flow?
The current quarterly FCF of BTTX is -$5.88 M
What is the all time high quarterly FCF for Better Therapeutics?
Better Therapeutics all-time high quarterly free cash flow is -$3.20 M
What is Better Therapeutics TTM free cash flow?
The current TTM FCF of BTTX is -$27.40 M
What is the all time high TTM FCF for Better Therapeutics?
Better Therapeutics all-time high TTM free cash flow is -$3.20 M